5AM Venture Management

5AM Venture Management as of Sept. 30, 2024

Portfolio Holdings for 5AM Venture Management

5AM Venture Management holds 28 positions in its portfolio as reported in the September 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Entrada Therapeutics (TRDA) 14.6 $70M 4.4M 15.98
Enliven Therapeutics (ELVN) 9.2 $45M 1.8M 25.54
Skye Bioscience Com New (SKYE) 8.0 $39M 9.9M 3.91
Artiva Biotherapeutics 7.5 $36M 2.4M 15.45
Dianthus Therapeutics (DNTH) 7.0 $34M 1.2M 27.38
Biohaven (BHVN) 4.9 $24M 479k 49.97
Tyra Biosciences (TYRA) 4.6 $22M 939k 23.51
Centessa Pharmaceuticals Sponsored Ads (CNTA) 4.2 $21M 1.3M 15.99
Tectonic Therapeutic (TECX) 4.0 $20M 647k 30.30
Praxis Precision Medicines I Com New (PRAX) 4.0 $20M 340k 57.54
Celldex Therapeutics Com New (CLDX) 3.5 $17M 497k 33.99
Miragen Therapeutics (VRDN) 3.5 $17M 737k 22.75
Viking Therapeutics (VKTX) 3.1 $15M 238k 63.31
Pharvaris N V (PHVS) 3.1 $15M 798k 18.52
Erasca (ERAS) 3.0 $15M 5.4M 2.73
Moonlake Immunotherapeutics Class A Ord (MLTX) 2.9 $14M 282k 50.42
Anaptysbio Inc Common (ANAB) 2.5 $12M 358k 33.50
Silence Therapeutics Ads (SLN) 1.8 $8.7M 476k 18.18
Eyepoint Pharmaceuticals Com New (EYPT) 1.7 $8.4M 1.1M 7.99
Cogent Biosciences (COGT) 1.3 $6.1M 562k 10.80
Scpharmaceuticals (SCPH) 1.1 $5.5M 1.2M 4.56
Vor Biopharma (VOR) 0.9 $4.5M 6.4M 0.70
Rallybio Corp (RLYB) 0.9 $4.2M 3.6M 1.17
Gh Research Ordinary Shares (GHRS) 0.8 $3.8M 573k 6.69
Adverum Biotechnologies Com New (ADVM) 0.8 $3.8M 542k 7.02
Mersana Therapeutics (MRSN) 0.5 $2.5M 1.3M 1.89
Zentalis Pharmaceuticals (ZNTL) 0.4 $1.8M 490k 3.68
Cidara Therapeutics Com New (CDTX) 0.1 $610k 57k 10.75